USE OF ALENDRONATE FOR THE PREVENTION OF OSTEOPOROSIS

(19)

(11)

EP 0 828 496 A1

(12)

(43)	Date of publication:
	18.03.1998 Bulletin 1998/12

(21)	Application number: 96920553.0

(22)	Date of filing: 29.05.1996

(51)

International Patent Classification (IPC):

A61K^{( . )}
A61K 31/ 66^{( . )}
A61P 3/ 02^{( . )}
A61P 43/ 00^{( . )}

C07F^{( . )}
A61K 31/ 663^{( . )}
A61P 19/ 10^{( . )}

(86)	International application number:
	PCT/US1996/007912

(87)	International publication number:
	WO 1996/038156 (05.12.1996 Gazette 1997/01)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
	Designated Extension States:
	LT LV SI

(30)

Priority:

02.06.1995 US 19950458195

(71)	Applicant: MERCK & CO., INC.
	Rahway, New Jersey 07065 (US)

(72)	Inventor:
	YATES, Ashley, J. Rahway, NJ 07065 (US)

(74)	Representative: Horgan, James Michael Frederic, et al
	Merck & Co., Inc., Terlings Park, Eastwick Road Harlow, Essex CM20 2QR Harlow, Essex CM20 2QR (GB)

(54)	USE OF ALENDRONATE FOR THE PREVENTION OF OSTEOPOROSIS